Plus, news about Atlas Venture:
NICE plans a limited rollout of Eli Lilly’s Zepbound: The UK’s drug price watchdog confirmed its
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
In a prelude to what is hoped will be regulatory approval of MDMA-assisted therapy in the U.S. and Canada, Numinus Wellness Inc. (TSE: NUMI) (OTCMKTS: NUMIF) has taken steps
A recent study in PNAS reveals that the expansion of large-scale pig rearing has led to the emergence of novel, highly pathogenic Streptococcus suis strains,
An FDA advisory committee voted against backing Lykos Therapeutics’ MDMA-based therapy for post-traumatic stress disorder, a blow to the biotech company’s efforts to bring the